Kingston is an incubator for biotechnology discovery and commercialization.  Equipped with powerful research and academic resources, a high tech infrastructure and its own venture capital fund, Kingston attracts some of the best and brightest minds from around the globe.

Collectively, their work generates high-value intellectual property which has been licensed to existing companies and has led to the creation of a number of Kingston-based spin-off biotechnology companies.

Key to Kingston´s success in this sector is PARTEQ Innovations of Queen´s University.  Its unique hands-on approach to technology transfer has made it the model for successful technology transfer in Canada.

To ensure successful commercialization and the return on investment from that commercialization, PARTEQ provides funding, business development, recruitment of key talent, and intellectual property management to its partners.  This leads to unique working relationships between academic investigators and their private sector partners and has resulted in more than 40 startup companies, many of them in Kingston, including AdapCS Canada Corp., AtheroChem, Inc., Biosystemix Ltd., BKIN Techologies Ltd., Improved Outcomes Software Inc., Performance Plants, Inc., Qubit Systems Inc. and Xuuk, Inc.

For more information on Kingston´s Biotechnology sector, please contact business@kingstoncanada.com.